company. “Tollovid is a uniquely positioned product for today’s challenges, and the ability to supply it and other Todos products that empower consumers to take greater control of their wellbeing is a game-changing opportunity for us to deliver for our grocery store and airport clients. More and more people are getting their immune support products from the pharmacy section in grocery stores, and so we see Tollovid being on the leading edge of trend.”
Under the terms of the new 5-year agreement, Todos has the exclusive right to distribute immune support products into SARN’s 21,853 grocery store locations nationwide, and into SARN’s airport locations, including in Atlanta (ATL), Dallas (DFW), Denver (DEN), Chicago (ORD), Los Angeles (LAX), Charlotte (CLT), Orlando (MCO), Las Vegas (LAS) and more. Smart Automated Retail Network’s ownership’s previous experience includes the distribution of iStore, Best Buy, Kylie Cosmetics, LVMH Benefits and ReachTV. Todos Medical, through its majority-controlled subsidiary 3CL Pharma, Inc., distributes the 3CL protease inhibitor immune support dietary supplement Tollovid™. Tollovid is not approved by the US FDA to diagnose, treat, prevent or cure any disease including COVID and/or Long COVID. Todos Medical, through its wholly owned subsidiary Todos Botanicals, LLC, also distributes immune support supplements, including hemp-based CBD products. Todos will supply Tollovid, CBD products and other immune support supplements through SARN’s automated retail locations.
“We are extremely pleased to have been able to establish a direct relationship with Smart Automated Retail Network because of the increased distribution and marketing reach it brings to us as we execute on the next phase of the physical store rollout strategy for Tollovid,” said Gerald E. Commissiong, President & CEO of Todos Medical. “Being able to leverage Affy’s relationships to get reach into the traditional retail shelf space market also represents a significant benefit for us. We believe these steps will be of critical importance as Tollovid moves to the next stage of growth.”
According to Grandview Research, the global retail vending machine market size was valued at USD $51.91 billion in 2021 and is expected to register a compound annual growth rate (CAGR) of 10.7% from 2022 to 2030, leading to a market size of $132 billion by 2028. Consumers now want easy access to supplements, and with the commoditization of CBD its usage has become mainstream. The vending machine approach of our rollout capitalizes on the key drivers of unattended retail that consumers want for convenience with high quality CBD products and Tollovid. Grocery stores, airports, universities, sporting venues, and fitness centers are high traffic areas where consumers on the go would pay more for the convenience of Tollovid and CBD products. In a separate report, Grandview research noted: “The global immune health supplements market size was valued at USD $55.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2021 to 2028, expected to reach $132 billion by 2028. The key factors driving market growth include the increasing prevalence of infectious diseases, diabetes, and several other disorders due to lack of immunity. In recent years, there has been a constant trend observed about the increase in supplement usage to improve the body's immunity all over the globe. Due to the COVID19 pandemic, there is significant consumer interest in the use of immune health supplements. In 2019, according to the Council for Responsible Nutrition (CRN), about 73% of Americans consumed dietary supplements and from that, about 32% are consuming the dietary supplements to improve their immune health. The increasing consumer awareness to maintain and improve immune health and wellbeing is expected to drive the market over the forecast years.”
To learn more about the 3CL protease in SARS-CoV-2 replication, please visit www.3clpro.com
https://investor.todosmedical.com/news-events...-automated
Under the terms of the new 5-year agreement, Todos has the exclusive right to distribute immune support products into SARN’s 21,853 grocery store locations nationwide, and into SARN’s airport locations, including in Atlanta (ATL), Dallas (DFW), Denver (DEN), Chicago (ORD), Los Angeles (LAX), Charlotte (CLT), Orlando (MCO), Las Vegas (LAS) and more. Smart Automated Retail Network’s ownership’s previous experience includes the distribution of iStore, Best Buy, Kylie Cosmetics, LVMH Benefits and ReachTV. Todos Medical, through its majority-controlled subsidiary 3CL Pharma, Inc., distributes the 3CL protease inhibitor immune support dietary supplement Tollovid™. Tollovid is not approved by the US FDA to diagnose, treat, prevent or cure any disease including COVID and/or Long COVID. Todos Medical, through its wholly owned subsidiary Todos Botanicals, LLC, also distributes immune support supplements, including hemp-based CBD products. Todos will supply Tollovid, CBD products and other immune support supplements through SARN’s automated retail locations.
“We are extremely pleased to have been able to establish a direct relationship with Smart Automated Retail Network because of the increased distribution and marketing reach it brings to us as we execute on the next phase of the physical store rollout strategy for Tollovid,” said Gerald E. Commissiong, President & CEO of Todos Medical. “Being able to leverage Affy’s relationships to get reach into the traditional retail shelf space market also represents a significant benefit for us. We believe these steps will be of critical importance as Tollovid moves to the next stage of growth.”
According to Grandview Research, the global retail vending machine market size was valued at USD $51.91 billion in 2021 and is expected to register a compound annual growth rate (CAGR) of 10.7% from 2022 to 2030, leading to a market size of $132 billion by 2028. Consumers now want easy access to supplements, and with the commoditization of CBD its usage has become mainstream. The vending machine approach of our rollout capitalizes on the key drivers of unattended retail that consumers want for convenience with high quality CBD products and Tollovid. Grocery stores, airports, universities, sporting venues, and fitness centers are high traffic areas where consumers on the go would pay more for the convenience of Tollovid and CBD products. In a separate report, Grandview research noted: “The global immune health supplements market size was valued at USD $55.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2021 to 2028, expected to reach $132 billion by 2028. The key factors driving market growth include the increasing prevalence of infectious diseases, diabetes, and several other disorders due to lack of immunity. In recent years, there has been a constant trend observed about the increase in supplement usage to improve the body's immunity all over the globe. Due to the COVID19 pandemic, there is significant consumer interest in the use of immune health supplements. In 2019, according to the Council for Responsible Nutrition (CRN), about 73% of Americans consumed dietary supplements and from that, about 32% are consuming the dietary supplements to improve their immune health. The increasing consumer awareness to maintain and improve immune health and wellbeing is expected to drive the market over the forecast years.”
To learn more about the 3CL protease in SARS-CoV-2 replication, please visit www.3clpro.com
https://investor.todosmedical.com/news-events...-automated
1
